Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer

Int J Nanomedicine. 2020 Oct 22:15:8151-8166. doi: 10.2147/IJN.S272529. eCollection 2020.

Abstract

Conventional taxanes are used as cornerstone of the chemotherapeutical treatment for a variety of malignancies. Nevertheless, a large proportion of patients do not benefit from their treatment while they do suffer from severe adverse events related to the solvent or to the active compound. Cremophor EL and polysorbate 80 free formulations, conjugates, oral formulations and different types of drug delivery systems are some examples of the several attempts to improve the treatment with taxanes. In this review article, we discuss recent clinical developments of nanomediated drug delivery systems of taxanes for the treatment of cancer. Targeting mechanisms of drug delivery systems and characteristics of the most commonly used taxane-containing drug delivery systems in the clinical setting will be discussed in this review.

Keywords: cancer; drug delivery systems; nanomedicine; nanoparticle; taxane.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use
  • Drug Carriers / administration & dosage
  • Drug Carriers / chemistry
  • Drug Delivery Systems / methods*
  • Humans
  • Nanostructures / administration & dosage*
  • Nanostructures / chemistry
  • Nanostructures / therapeutic use
  • Neoplasms / drug therapy
  • Taxoids / administration & dosage*
  • Taxoids / pharmacokinetics
  • Taxoids / therapeutic use

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Taxoids